Market Overview

Benzinga's Top Initiations

Related IRWD
Ironwood Presents IW-9179 Phase IIa Data At American College Of Gastroenterology 2014 Annual Scientific Meeting
Ironwood Pharmaceuticals Announces Initiation Of Phase II Trial Of Linaclotide In Adult Patients With Opioid-Induced Constipation
Related BKW
McDonald's Shares Spike After Ackman Declines To Comment
Morningstar Analyst On McDonald's: Activist Investor Could Push For Management Change, Franchise Increase
Protesters Rekindle Minimum Wage Fight in 190 Cities (Fox Business)

Analysts at Credit Suisse initiated coverage on shares of Ironwood Pharmaceuticals (NASDAQ: IRWD) with an “outperform” rating. The target price for Ironwood Pharmaceuticals is set to $16. Ironwood's shares closed at $11.31 yesterday.

Wells Fargo initiated coverage on shares of Burger King Worldwide (NYSE: BKW) with a “market perform” rating. Burger King's shares closed at $20.27 yesterday.

Stifel Nicolaus initiated coverage on shares of Gartner (NYSE: IT) with a “buy” rating. The target price for Gartner is set to $67. Gartner's stock closed at $56.41 yesterday.

Analysts at Wells Fargo initiated coverage on shares of Exxon Mobil (NYSE: XOM) with a “market perform” rating. Exxon Mobil's shares closed at $89.05 yesterday.

Latest Ratings for IRWD

DateFirmActionFromTo
Dec 2014JP MorganMaintainsOverweight
Nov 2014Cantor FitzgeraldDowngradesHoldSell
Sep 2014Cowen & CompanyDowngradesOutperformMarket Perform

View More Analyst Ratings for IRWD
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (IRWD + BKW)

Around the Web, We're Loving...

Get Benzinga's Newsletters